Hypertension Diagnostics Probability of Future Pink Sheet Price Finishing Under 0.00
| HDIIDelisted Stock | USD 0 0.0008 38.10% |
Hypertension |
Hypertension Diagnostics Target Price Odds to finish below 0.00
The tendency of Hypertension Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to drop to $ 0.00 or more in 90 days |
| 0 | 90 days | 0.00 | near 1 |
Based on a normal probability distribution, the odds of Hypertension Diagnostics to drop to $ 0.00 or more in 90 days from now is near 1 (This Hypertension Diagnostics probability density function shows the probability of Hypertension Pink Sheet to fall within a particular range of prices over 90 days) . Probability of Hypertension Diagnostics price to stay between $ 0.00 and its current price of $0.0029 at the end of the 90-day period is about 54.79 .
Given the investment horizon of 90 days the pink sheet has the beta coefficient of 5.1 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Hypertension Diagnostics will likely underperform. Additionally Hypertension Diagnostics has an alpha of 0.881, implying that it can generate a 0.88 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Hypertension Diagnostics Price Density |
| Price |
Predictive Modules for Hypertension Diagnostics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Hypertension Diagnostics. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Hypertension Diagnostics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Hypertension Diagnostics is not an exception. The market had few large corrections towards the Hypertension Diagnostics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Hypertension Diagnostics, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Hypertension Diagnostics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.88 | |
β | Beta against Dow Jones | 5.10 | |
σ | Overall volatility | 0.0006 | |
Ir | Information ratio | 0.09 |
Hypertension Diagnostics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Hypertension Diagnostics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Hypertension Diagnostics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Hypertension Diagnostics is not yet fully synchronised with the market data | |
| Hypertension Diagnostics has some characteristics of a very speculative penny stock | |
| Hypertension Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| Hypertension Diagnostics currently holds 4.69 M in liabilities. Hypertension Diagnostics has a current ratio of 0.51, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Hypertension Diagnostics until it has trouble settling it off, either with new capital or with free cash flow. So, Hypertension Diagnostics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Hypertension Diagnostics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Hypertension to invest in growth at high rates of return. When we think about Hypertension Diagnostics' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 3.79 M. Net Loss for the year was (125.39 K) with profit before overhead, payroll, taxes, and interest of 954.47 K. | |
| Hypertension Diagnostics currently holds about 5.66 K in cash with (389.28 K) of positive cash flow from operations. |
Hypertension Diagnostics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Hypertension Pink Sheet often depends not only on the future outlook of the current and potential Hypertension Diagnostics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Hypertension Diagnostics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 52.4 M |
Hypertension Diagnostics Technical Analysis
Hypertension Diagnostics' future price can be derived by breaking down and analyzing its technical indicators over time. Hypertension Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Hypertension Diagnostics. In general, you should focus on analyzing Hypertension Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
Hypertension Diagnostics Predictive Forecast Models
Hypertension Diagnostics' time-series forecasting models is one of many Hypertension Diagnostics' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Hypertension Diagnostics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about Hypertension Diagnostics
Checking the ongoing alerts about Hypertension Diagnostics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Hypertension Diagnostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Hypertension Diagnostics is not yet fully synchronised with the market data | |
| Hypertension Diagnostics has some characteristics of a very speculative penny stock | |
| Hypertension Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| Hypertension Diagnostics currently holds 4.69 M in liabilities. Hypertension Diagnostics has a current ratio of 0.51, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Hypertension Diagnostics until it has trouble settling it off, either with new capital or with free cash flow. So, Hypertension Diagnostics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Hypertension Diagnostics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Hypertension to invest in growth at high rates of return. When we think about Hypertension Diagnostics' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 3.79 M. Net Loss for the year was (125.39 K) with profit before overhead, payroll, taxes, and interest of 954.47 K. | |
| Hypertension Diagnostics currently holds about 5.66 K in cash with (389.28 K) of positive cash flow from operations. |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Consideration for investing in Hypertension Pink Sheet
If you are still planning to invest in Hypertension Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Hypertension Diagnostics' history and understand the potential risks before investing.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |